Plant Extract Composition for Cardio-Metabolic Risk Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmacological therapies for cardiovascular and metabolic diseases often come with significant side effects, leading to therapy discontinuation and increased risk of cardiovascular events. Additionally, there is a need for safer, more effective alternatives for individuals intolerant to standard treatments or requiring polytherapy.
Innovation Solution
A composition combining Opuntia ficus indica extract with Bergamot extract, plant sterols, and a trace element like Vitamin B1 (Thiamine), which is formulated to reduce cardio-metabolic risk factors without the side effects associated with traditional medications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmacological therapies (statins, metformin) are used to treat cardiovascular and metabolic diseases, then therapeutic efficacy is improved, but side effects increase leading to therapy discontinuation
Solution Approach 1:
The patent changes the chemical composition parameters by replacing synthetic pharmaceutical compounds with plant-derived extracts (Opuntia ficus indica, bergamot, plant sterols). This parameter change maintains therapeutic efficacy for lipid and glucose metabolism while eliminating the harmful side effects associated with conventional drugs like statins and metformin.
Solution Approach 2:
The patent employs naturally occurring plant extracts that can be replenished through diet and supplementation, replacing long-term pharmaceutical dependence. These natural compounds offer a renewable, accessible alternative that reduces reliance on prescription medications with cumulative side effects.
2Adaptability or versatility
If polytherapy is used to address multifactorial cardiovascular risk, then comprehensive treatment coverage is improved, but side effects and therapy abandonment increase
Solution Approach 1:
The patent merges multiple therapeutic functions into a single multi-component plant extract formulation. Opuntia ficus indica, bergamot extract, and plant sterols work synergistically to address lipid metabolism, glucose control, and cardiovascular protection simultaneously, replacing the need for multiple separate pharmaceutical agents.
Solution Approach 2:
The plant extract composition exhibits multi-functionality by addressing multiple cardiovascular risk factors (dyslipidemia, insulin resistance, hypertension) through a single therapeutic intervention. This universal approach maintains comprehensive treatment coverage while avoiding the cumulative side effects of polypharmacy.
3Reliability
If standard pharmacological treatments are used for dyslipidemia and diabetes, then metabolic control is improved, but quality of life decreases due to side effects
Solution Approach 1:
The patent introduces plant sterols and phytochemicals as intermediary substances that mediate between dietary intake and metabolic regulation. These natural compounds act as intermediaries to improve lipid and glucose metabolism without the harsh physiological effects of pharmaceutical interventions, thereby maintaining metabolic control while preserving quality of life.
Data Source
AI summary
The present invention relates to a composition containing Opuntia ficus indica extract and at least one substance selected from among Bergamot extract (Citrus Bergamia) and/or Lemon and/or Orange and/or Pomelo and/or Grapefruit, preferably Bergamot extract, phytosterols, and at least one trace element.